Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,597.00
-3.00 (-0.19%)
Jul 6, 2026, 3:22 PM GMT
Bioventix Market Cap
Bioventix has a market cap or net worth of 83.6 million as of July 6, 2026. Its market cap has decreased by -39.62% in one year.
Market Cap
83.60M
Enterprise Value
78.29M
Revenue
12.54M
Ranking
n/a
PE Ratio
11.39
Stock Price
1,597.00
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 83.60M, an increase of 748.92%. That is a compound annual growth rate of 14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 83.60M | -16.01% |
| Dec 31, 2025 | 99.53M | -39.94% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 292.59M |
| Scancell Holdings | 147.88M |
| Faron Pharmaceuticals Oy | 94.23M |
| 4basebio | 81.58M |
| Ondine Biomedical | 77.41M |
| Hemogenyx Pharmaceuticals | 52.36M |
| hVIVO | 49.12M |
| Poolbeg Pharma | 48.30M |